Clinical review of hereditary angioedema: Diagnosis and management

Postgraduate Medicine

Volumn 121, Issue 6, 2009, Pages 113-120

  Weis, Mark ^a  

^a Irwin Army Community Hospital   (United States)

Author keywords

Angioedema; Bradykinin; Cl inhibitor; Hereditary; Inherited; Swelling

Indexed keywords

ADRENALIN; AMINOCAPROIC ACID; ANDROGEN; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIFIBRINOLYTIC AGENT; ANTIHISTAMINIC AGENT; BRADYKININ ANTAGONIST; COMPLEMENT COMPONENT C1S INHIBITOR; CORTICOSTEROID; DANAZOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FRESH FROZEN PLASMA; KALLIKREIN INHIBITOR; PREDNISONE; TRANEXAMIC ACID; ANTIESTROGEN; BRADYKININ; SERPING1 PROTEIN, HUMAN;

ABDOMINAL PAIN; ACNE; ACUTE PANCREATITIS; ANGIONEUROTIC EDEMA; AUTOSOMAL DOMINANT INHERITANCE; CLINICAL FEATURE; CLINICAL TRIAL; COMPLEMENT BLOOD LEVEL; DEEP VEIN THROMBOSIS; DEPRESSION; DIAGNOSTIC ERROR; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG WITHDRAWAL; FAMILY HISTORY; HEADACHE; HEART INFARCTION; HUMAN; INJURY; LABORATORY TEST; LIVER ADENOMA; MENSTRUAL IRREGULARITY; MUSCLE SPASM; MYALGIA; NAUSEA; OFF LABEL DRUG USE; ONSET AGE; PAIN; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; RASH; REVIEW; RISK FACTOR; SIDE EFFECT; SINUSITIS; STROKE; SWELLING; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; UPPER RESPIRATORY TRACT INFECTION; VIRILIZATION; VOMITING; WEIGHT GAIN; ADOLESCENT; ADULT; EMERGENCY; METABOLISM;

ADOLESCENT; ADULT; ANGIOEDEMAS, HEREDITARY; BRADYKININ; COMPLEMENT C1 INACTIVATOR PROTEINS; COMPLEMENT C1 INHIBITOR PROTEIN; DANAZOL; EMERGENCIES; ESTROGEN ANTAGONISTS; HUMANS;

EID: 73949107892     PISSN: 00325481     EISSN: 19419260     Source Type: Journal    
DOI: 10.3810/pgm.2009.11.2071     Document Type: Review

References (27)

1. Frank MM. Hereditary angioedema: the clinical syndrome and its management in the United States. Immunol Allergy Clin North Am. 2006;26(4):653-668.
2. Agostoni A, Aygoren-Pursun E, Binkley KE, et al. Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond. J Allergy Clin Immunol. 2004;114(3 suppl):S51-S131.
3. Nzeako UC, Frigas E, Tremaine WJ. Hereditary angioedema: a broad review for clinicians. Arch Intern Med. 2001;161(20):2417-2429.
4. Gompels MM, Lock RJ, Abinun M, et al. C1 inhibitor deficiency: consensus document. Clin Exp Immunol. 2005;139(3):379-394.
5. Bork K, Barnstedt SE, Koch P, Traupe H. Hereditary angioedema with normal C1-inhibitor activity in women. Lancet. 2000;356(9225):213-217.
6. Zuraw BL. Clinical practice. Hereditary angioedema. N Engl J Med. 2008;359(10):1027-1036.
7. Bowen T, Cicardi M, Bork K, et al. Hereditary angiodema: a current state-of-the-art review, VII: Canadian Hungarian 2007 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema. Ann Allergy Asthma Immunol. 2008;100(1 suppl 2):S30-S40.
8. Bork K, Meng G, Staubach P, Hardt J. Hereditary angioedema: new findings concerning symptoms, affected organs, and course. Am J Med. 2006;119(3):267-274.
9. Bouillet L, Longhurst H, Boccon-Gibod I, et al. Disease expression in women with hereditary angioedema. Am J Obstet Gynecol. 2008;199(5):484.
10. Moore GP, Hurley WT, Pace SA. Hereditary angioedema. Ann Emerg Med. 1988;17(10):1082-1086.
11. Agostoni A, Cicardi M. Hereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patients. Medicine (Baltimore). 1992;71(4):206-215.
12. Davis AE 3rd. Mechanism of angioedema in first complement component inhibitor deficiency. Immunol Allergy Clin North Am. 2006;26(4):633-651.
13. Frank MM, Gelfand JA, Atkinson JP. Hereditary angioedema: the clinical syndrome and its management. Ann Intern Med. 1976;84(5):580-593.
14. Zuraw BL. Hereditary angiodema: a current state-of-the-art review, IV: short- and long-term treatment of hereditary angioedema: out with the old and in with the new? Ann Allergy Asthma Immunol. 2008;100(1 suppl 2):S13-S18.
15. Bork K, Barnstedt SE. Laryngeal edema and death from asphyxiation after tooth extraction in four patients with hereditary angioedema. J Am Dent Assoc. 2003;134(8):1088-1094.
16. ARUPConsult. The physician's guide to laboratory test selection and interpretation: Hereditary angioedema. http://www.arupconsult.com/Topics/ AutoimmuneDz/HereditaryAngioedema.html. Accessed June 23, 2009.
17. Quest Diagnostics. Angioedema panel, hereditary, comprehensive. http://www.questdiagnostics.com/hcp/testmenu/jsp/showTestMenu.jsp?fn=17706.html. Accessed June 23, 2009.
18. Frigas E, Park M. Idiopathic recurrent angioedema. Immunol Allergy Clin North Am. 2006;26(4):739-751.
19. Byrd JB, Adam A, Brown NJ. Angiotensin-converting enzyme inhibitor-associated angioedema. Immunol Allergy Clin North Am. 2006;26(4):725-737.
20. Cicardi M, Zingale LC, Bergamaschini L, Agostoni A. Angioedema associated with angiotensin-converting enzyme inhibitor use: outcome after switching to a different treatment. Arch Intern Med. 2004;164(8):910-913.
21. Grigoriadou S, Longhurst HJ. Clinical Immunology Review Series: An approach to the patient with angio-oedema. Clin Exp Immunol. 2009;155(3):367-377.
22. CINRYZE [package insert]. New York, NY: Lev Pharmaceuticals; 2008.
23. Danocrine [package insert]. New York, NY: Sanofi-Synthelabo; 2003.
24. Epstein TG, Bernstein JA. Current and emerging management options for hereditary angioedema in the US. Drugs. 2008;68(18):2561-2573.
25. Bork K, Bygum A, Hardt J. Benefits and risks of danazol in hereditary angioedema: a long-term survey of 118 patients. Ann Allergy Asthma Immunol. 2008;100(2):153-161.
26. Berinert [package insert]. Kankakee, IL: CSL Behring: 2009.
27. Hereditary Angioedema Association. Angioedema types. http://www.haea.org. Accessed June 23, 2009.